A Strain Change Study for SARS-CoV-2 rS Vaccines

Clinical trial NCT06409663 · COMPLETED

Trial details

NCT number: NCT06409663
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Start date: 2024-10-14
Primary completion: 2024-10-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.